LU86418A1 - NITROGENED POLYSACCHARIDES AND THEIR PROCESS FOR OBTAINING - Google Patents
NITROGENED POLYSACCHARIDES AND THEIR PROCESS FOR OBTAINING Download PDFInfo
- Publication number
- LU86418A1 LU86418A1 LU86418A LU86418A LU86418A1 LU 86418 A1 LU86418 A1 LU 86418A1 LU 86418 A LU86418 A LU 86418A LU 86418 A LU86418 A LU 86418A LU 86418 A1 LU86418 A1 LU 86418A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- zymomonas
- pediococcus
- culture broth
- fermentation
- inoculated
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 21
- 229920001282 polysaccharide Polymers 0.000 title claims description 21
- 239000005017 polysaccharide Substances 0.000 title claims description 21
- 230000008569 process Effects 0.000 title claims description 11
- 150000004676 glycans Chemical class 0.000 title claims description 8
- 238000000855 fermentation Methods 0.000 claims description 16
- 230000004151 fermentation Effects 0.000 claims description 16
- 238000001179 sorption measurement Methods 0.000 claims description 14
- -1 Nitrogenous polysaccharides Chemical class 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 241000588901 Zymomonas Species 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000011081 inoculation Methods 0.000 claims description 6
- 241000192001 Pediococcus Species 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 230000009089 cytolysis Effects 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 206010061598 Immunodeficiency Diseases 0.000 claims description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 206010054979 Secondary immunodeficiency Diseases 0.000 claims description 2
- 238000005273 aeration Methods 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 230000007123 defense Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 230000007813 immunodeficiency Effects 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 241000894007 species Species 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960001438 immunostimulant agent Drugs 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000007792 addition Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910021432 inorganic complex Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 238000009344 polyculture Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RIAJLMJRHLGNMZ-UHFFFAOYSA-N triazanium;trioxomolybdenum;phosphate Chemical compound [NH4+].[NH4+].[NH4+].O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.[O-]P([O-])([O-])=O RIAJLMJRHLGNMZ-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
- * ' r "Polysaccharides azotés et leur procédé d'obtention"- * 'r "Nitrogenous polysaccharides and their production process"
La présente invention est relative, d'une manière générale, à des polysaccharides azotés et à leur procédé d'obtention. Elle se réfère en particulier à un procédé d'obtention de tels polysaccharides azotés, qui consiste en un procédé de fermentation durant lequel 5 un composé polysaccharide azoté se forme dans le bouillon de culture, ce composé étant ensuite isolé du bouillon de culture sous la forme d'un produit d'adsorption, et ce comme on le décrira de façon plus complète ci-après.The present invention relates, in general, to nitrogenous polysaccharides and to their process for obtaining. It refers in particular to a process for obtaining such nitrogenous polysaccharides, which consists of a fermentation process during which a nitrogenous polysaccharide compound is formed in the culture broth, this compound then being isolated from the culture broth in the form of an adsorption product, and this will be described more fully below.
La fermentation est menée à bien d'une manière 10 originale, en utilisant d'abord, comme inoculum du milieu de culture, un micro-organisme du genre Zymomonas durant les premiers jours de la fermentation, et en réalisant ensuite un autre ensemencement dans le même bouillon de culture qui en est ainsi modifié, et ce en utilisant le Pediococcus acidilactici, puis en poursuivant le procédé 15 jusqu'à obtention, dans le bouillon de culture, du composé recherché et en séparant ensuite celui-ci grâce à la formation d'un produit d'adsorption qui contient la quasi totalité de ce composé.The fermentation is carried out in an original manner, first using, as inoculum of the culture medium, a microorganism of the genus Zymomonas during the first days of the fermentation, and then carrying out another sowing in the same culture broth which is thus modified therefrom, using Pediococcus acidilactici, then continuing the process 15 until the desired compound is obtained in the culture broth and then separating it thanks to the formation of 'an adsorption product which contains almost all of this compound.
? Par conséquent, on utilise une fermentation que l'on pourrait appeler "à cultures associées", que le Dr. 3. Risler définit 20 dans son ouvrage "Les complexes antibiotiques d'adaptation" (PACOMHY Editeurs, 7 rue Gustave-Nadaud, Paris (16e), ou à culture mixte ("fermentation à culture mixte"), dénomination due à C.W. Hesseltine (Ann. Rev. Microbiol. 37,575-601-1983), travail dans lequel on étudie l'obtention de différents aliments grâce à une fermentation en utilisant des 25 cultures mixtes.? Consequently, a fermentation which one could call "associated cultures" is used, which Dr. 3. Risler defines 20 in his work "Antibiotic adaptation complexes" (PACOMHY Editeurs, 7 rue Gustave-Nadaud, Paris (16th), or mixed culture ("fermentation mixed culture"), name due to CW Hesseltine (Ann. Rev. Microbiol. 37,575-601-1983), work in which we study obtaining different foods through a fermentation using 25 mixed cultures.
Le procédé de fermen ation suivant la présente invention diffère de la technique que le dernier auteur mentionné appelle "polyculture", en ce sens que bien que l'on utilise plus d'un micro-organis- V » 2 me pour la fermentation et l'obtention du composé final désiré, ces micro-organismes sont inconnus, tandis que, dans le présent cas, on inocule le bouillon par des cultures pures des deux micro-organismes - mentionnés antérieurement, en prévoyant un déphasage entre les addi- 5 tions de ces micro-organismes. Le mode opératoire est original et v présente divers avantages, comme par exemple de permettre une vitesse plus grande de croissance des deux germes, une association stable de ceux-ci, une résistance beaucoup plus grande à l'action des phagocytes et un meilleur rendement du composé désiré, ainsi que la possibilité 10 d'employer des substrats mixtes dans la préparation du milieu de culture.The fermen ation method according to the present invention differs from the technique which the last mentioned author calls "polyculture", in the sense that although more than one microorganism is used for fermentation and l When the desired final compound is obtained, these microorganisms are unknown, while in the present case the broth is inoculated with pure cultures of the two microorganisms - mentioned previously, providing for a phase shift between the additions of these microorganisms. The procedure is original and has various advantages, such as allowing a faster rate of growth of the two germs, a stable association of these, a much greater resistance to the action of phagocytes and a better yield of desired compound, as well as the possibility of employing mixed substrates in the preparation of the culture medium.
L'exemple suivant illustre suffisamment l'invention.The following example sufficiently illustrates the invention.
Dans un récipient métallique (de préférence en acier inoxydable), on place 90 kg de graines de soja et on lave deux fois à l'eau, on élimine les liquides de lavage et on ajoute ensuite de l'eau 15 en une quantité suffisante pour que les graines soient totalement recouvertes par cette eau. On obture le récipient et on laisse tremper à la température de 10 à Ô'C environ (cette température n’est pas critique) durant environ 18 heures. Ce temps de macération étant écoulé, on procède à une mouture grossière, à l'état humide, des semences 20 qui formeront ensuite une partie du bouillon de culture. Dans le cas présent, le procédé représente une modification importante comparativement aux techniques normales de fermentation, dans lesquelles, dans la préparation du bouillon de culture en vue de sa fermentation ultérieure, dans le but d'obtenir des composés ayant une action thérapeu-* 25 tique, on utilise toujours des ingrédients moulus finement ("farinesi'), en procédant, dès que le bouillon a été préparé, à sa stérilisation avant l'ensemencement du micro-organisme producteur de la fermentation. Dans le cas de l'invention, lorsque le processus de mouture grossière à l'état humide est terminé, on décante l'eau, en récupérant de celle-ci 30 la partie solide constituée par les graines de soja subdivisées qui, sans stérilisation, sont placées dans un fermentateur d'un volume utile de travail d'environ 14.000 à 15.000 litres, appareil pourvu d'un système d'agitation et dans lequel on a ajouté précédemment environ 3.000 litre d'eau à une température de 39-40°C (cette température 35 n'est pas critique). En entretenant une agitation modérée, on ajoute 3 les composants suivants du milieu de culture, ces composants ayant été préalablement pulvérisés finement. L'addition se fait dans l'ordre suivant : camphre cristallisé : 65 kg ; soufre micronisé : 65 kg ; colopha-- ne : 40 kg ; extrait sec de levure : 75 kg ; bioxyde de manganèse : 5 2,5 kg ; et sulfate de manganèse : 75 kg. Lorsque l'addition de ces composants est terminée, on ajoute dans le fermentateur, sans arrêter l'agitation, de l'eau à une température de 39°C +_ 2°C environ, jusqu'à atteindre un volume final de 13.000 litres, la préparation du bouillon de culture étant ainsi terminée.In a metal container (preferably stainless steel), 90 kg of soybeans are placed and washed twice with water, the washing liquids are eliminated and water is then added in an amount sufficient to that the seeds are completely covered by this water. The container is closed and left to soak at a temperature of approximately 10 to ÔC (this temperature is not critical) for approximately 18 hours. This maceration time having elapsed, a coarse grinding, in the wet state, of the seeds 20 is carried out which will then form part of the culture broth. In the present case, the process represents an important modification compared to normal fermentation techniques, in which, in the preparation of the culture broth for its subsequent fermentation, with the aim of obtaining compounds having a therapeutic action. tick, finely ground ingredients are always used ("farinesi"), proceeding, as soon as the broth has been prepared, to its sterilization before the inoculation of the microorganism producing fermentation. In the case of the invention, when the coarse grinding process in the wet state is finished, the water is decanted, recovering from it the solid part constituted by the subdivided soybeans which, without sterilization, are placed in a fermenter of a useful working volume of approximately 14,000 to 15,000 liters, apparatus provided with a stirring system and to which approximately 3,000 liters of water have previously been added at a temperature of 39-40 ° C (this temperature 35 is not not critical). Maintaining moderate agitation, the following 3 components of the culture medium are added, these components having been previously finely sprayed. The addition is made in the following order: crystallized camphor: 65 kg; micronized sulfur: 65 kg; rosin-- ne: 40 kg; dry yeast extract: 75 kg; manganese dioxide: 5 2.5 kg; and manganese sulfate: 75 kg. When the addition of these components is complete, water is added to the fermenter, without stopping the stirring, at a temperature of approximately 39 ° C. + 2 ° C., until a final volume of 13,000 liters is reached. , the preparation of the culture broth having thus been completed.
10 Lorsque le mélange a été préparé et homogénéisé, on vérifie sa température qui devra être maintenue de préférence à 39°C durant le processus de fermentation.When the mixture has been prepared and homogenized, its temperature is checked, which should preferably be maintained at 39 ° C during the fermentation process.
Ensemencement du bouillon de culture - Ensuite, on inocule le bouillon de culture par une souche de Zymomonas movilis. 15 La quantité d'inoculum que l'on utilise est de 10 cellules par litre de bouillon de culture, inoculum avec lequel on amorce le processus de fermentation. Le troisième jour, on procède à une nouvelle inoculation du bouillon par un micro-organisme différent du précédent, ce micro-organisme étant constitué par une souche dénommée Pediococcus 20 acidilactici, la quantité d'inoculum que l'on utilise dans ce cas étant 9 de 10 cellules par litre de bouillon. Le bouillon inocule est maintenu sans agitation ni aération à une température comprise entre 37 et 40°C sur une période de temps qui oscille entre 5 et 15 jours. Durant cette période, se produit le processus de fermentation et d'extraction B 25 des composants, et les modifications chimiques de ceux-ci, ainsi qu'une décantation graduelle qui provoque la formation, au sein du liquide, d'un gradient de solides, de particules et de micro-organismes.Inoculation of the culture broth - Next, the culture broth is inoculated with a strain of Zymomonas movilis. The quantity of inoculum which is used is 10 cells per liter of culture broth, inoculum with which the fermentation process is initiated. On the third day, a new inoculation of the broth is carried out by a microorganism different from the previous one, this microorganism consisting of a strain called Pediococcus 20 acidilactici, the quantity of inoculum used in this case being 9 10 cells per liter of broth. The inoculated broth is maintained without stirring or aeration at a temperature between 37 and 40 ° C over a period of time which varies between 5 and 15 days. During this period, the process of fermentation and extraction of the components takes place, and the chemical modifications of these components, as well as a gradual decantation which causes the formation, within the liquid, of a gradient of solids. , particles and microorganisms.
Lyse-hydrolyse - Le bouillon précédent est soumis à un processus de lyse -hydrolyse en ajoutant 120 kg d'acide phosphori-30 que à 85 % en poids, 120 kg d'urée en perles et 3,6 kg de pepsine en poudre d'un titre de 1/3.000.Lysis-hydrolysis - The previous broth is subjected to a lysis-hydrolysis process by adding 120 kg of phosphori-30 acid only at 85% by weight, 120 kg of urea in pearls and 3.6 kg of pepsin powder d '' a title of 1 / 3.000.
Tous les réactifs s'ajoutent sous agitation jusqu'à dissolution totale. Grâce à ce procédé, combiné à l'action du processus fermentatif décrit précédemment, on atteint les objectifs suivants : 35 lyse totale de tous les micro-organismes et solubilisation du polysaccha- » 4 ride contenant de l'azote, ainsi que sa modification chimique, de manière à ce que l'on obtienne le composé final désiré, non toxique et biologiquement actif. Les analyses montrent qu'à ce stade, la macromolécule unique qui subsiste comme telle est le polysaccharide contenant de 5 l'azote (PN).All reagents are added with stirring until complete dissolution. Thanks to this process, combined with the action of the fermentative process described above, the following objectives are achieved: complete lysis of all microorganisms and solubilization of the nitrogen-containing polysaccha- 4 ride, as well as its chemical modification , so as to obtain the desired final compound, non-toxic and biologically active. The analyzes show that at this stage, the single macromolecule which remains as such is the nitrogen-containing polysaccharide (PN).
Précipitation et formation du produit d'adsorption : le bouillon ayant ainsi subi une lyse est filtré sur de l'Hyflo Super-Cel ou un co-adjuvant de filtration ayant des propriétés analogues. Pour cela, on prépare une suspension de 5 kg de Hyflo Super-Cel dans 100 10 litres d'eau, avec laquelle se forme une couche dans un filtre-presse de 10 châssis de 40 x 40 cm, auquel on applique une pression d'entrée de 1 kg/cm2 en laissant la sortie libre. Ensuite et sans interrompre le courant, on procède à la filtration du lysat en maintenant la même pression dans le filtre. Ensuite, on ajoute, à la solution filtrée, 300 kg 15 de chlorure de calcium en scories (anhydre), on agite jusqu'à obtention d'une dissolution totale et on incorpore avec précaution de l'hydroxyde de sodium en solution à 10 % en poids/poids, jusqu'à ce que le pH ait une valeur d'environ 4,7. Le courant approximatif d'addition d'hydroxyde de sodium est d'environ 20 litres/minute.Precipitation and formation of the adsorption product: the broth which has thus undergone a lysis is filtered through Hyflo Super-Cel or a co-filter aid having similar properties. For this, a suspension of 5 kg of Hyflo Super-Cel is prepared in 100 10 liters of water, with which a layer is formed in a filter press of 10 frames of 40 x 40 cm, to which a pressure of 1 kg / cm2 inlet leaving the outlet free. Then and without interrupting the current, the lysate is filtered while maintaining the same pressure in the filter. Then 300 kg of calcium chloride slag (anhydrous) are added to the filtered solution, the mixture is stirred until complete dissolution is obtained and sodium hydroxide in a 10% solution is carefully incorporated. w / w, until the pH has a value of about 4.7. The approximate sodium hydroxide addition flow is approximately 20 liters / minute.
20 Cette opération étant terminée, on verse rapidement le total du liquide filtré et partiellement neutralisé sur 4.800 litres d'acétone pure. Ce changement de polarité du dissolvant détermine la formation d'un produit d'adsorption (sel complexe inorganique formé par du sulfate et du phosphate de calcium, dont l'analyse sera donnée » 25 dans la description chimique du composé) qui adsorbe pratiquement de façon sélective, la macromolécule constituée par le polysaccharide contenant de l'azote. Il se produit aussi des adsorptions de petites quantités de substances contaminantes (sucres réducteurs, bases azotées, aminoacides) mais ces substances s'éliminent quasi complètement 30 grâce à trois lavages successifs du produit d'adsorption avec 900 litres d'acétone à 28 % en volume/voiume dans de l'eau. On dessèche ces "eaux acétoniques" de lavage et la fraction solide en suspension dans ces eaux est séparée par filtration grâce à un filtre rotatif et est immédiatement séchée dans un four à air chaud à une température 35 de 40-60°C.This operation being completed, the total of the filtered and partially neutralized liquid is quickly poured onto 4,800 liters of pure acetone. This change in polarity of the solvent determines the formation of an adsorption product (inorganic complex salt formed by calcium sulphate and phosphate, the analysis of which will be given in the chemical description of the compound) which adsorbs practically so selective, the macromolecule constituted by the polysaccharide containing nitrogen. There is also adsorption of small quantities of contaminating substances (reducing sugars, nitrogenous bases, amino acids) but these substances are eliminated almost completely by three successive washes of the adsorption product with 900 liters of acetone at 28% in volume / volume in water. These washing "acetone waters" are dried and the solid fraction suspended in these waters is separated by filtration using a rotary filter and is immediately dried in a hot air oven at a temperature of 40-60 ° C.
* * 5* * 5
Tableau ITable I
Composition chimique du polysaccharide contenant de l'azote, ainsi que de son support inorganique - Polysaccharide de 5 Partie organique active manno-glucan 85,6 _+ 3,2 96 (2 % p/p) Protéines 14,4 _+3,2 96Chemical composition of the polysaccharide containing nitrogen, as well as its inorganic support - Polysaccharide of 5 Active organic part manno-glucan 85.6 _ + 3.2 96 (2% w / w) Proteins 14.4 _ + 3, 2 96
Support inorganique Sel complexe de phosphate calcique (98 96 p/p) contenant du soufre, sous forme de sulfate 10 Caractéristiques du produit d'adsorption - Poudre blanche, inodore et insipide (d'une saveur de craie), insoluble dans l'eau et soluble dans les acides inorganiques dilués, l'acide nitrique, l'acide chlorhydrique, etc., et dans les acides organiques forts, comme par exemple l'acide acétique.Inorganic support Complex calcium phosphate salt (98 96 w / w) containing sulfur, in the form of sulphate 10 Characteristics of the adsorption product - White powder, odorless and tasteless (with a chalk flavor), insoluble in water and soluble in dilute inorganic acids, nitric acid, hydrochloric acid, etc., and in strong organic acids, such as, for example, acetic acid.
15 Sa solution nitrique donne à chaud, avec le molybdate ammonique (solution réactive) un précipité jaune de phosphomolybdate ammonique, ce qui indique la présence de phosphates.Its nitric solution gives hot, with the ammonium molybdate (reactive solution) a yellow precipitate of ammonium phosphomolybdate, which indicates the presence of phosphates.
Sa solution dans de l'acide chlorhydrique dilué (2N) donne, avec une solution de chlorure de baryum (réactif) un précipité 20 blanc qui indique la présence de sulfates.Its solution in dilute hydrochloric acid (2N) gives, with a solution of barium chloride (reagent), a white precipitate which indicates the presence of sulphates.
La suspension aqueuse du produit d'adsorption traitée avec une solution du sel sodique de l'acide éthylènediamine-tétra-acéti-que, donne un liquide transparent et incolore par formation d'un complexe avec ce sel.The aqueous suspension of the adsorption product treated with a solution of the sodium salt of ethylenediamine-tetra-acetic acid gives a transparent and colorless liquid by forming a complex with this salt.
25 La solution du produit d'adsorption dans de l'acide acétique dilué donne, avec l'oxalate ammonique, un précipité blanc d'oxalate de calcium, ce qui indique la présence de calcium dans le produit d'adsorption.The solution of the adsorption product in dilute acetic acid gives, with the ammonium oxalate, a white precipitate of calcium oxalate, which indicates the presence of calcium in the adsorption product.
Tableau IITable II
30 Composition chimique du polysaccharide contenant de l'azote ; fraction polysaccharide Composition en monosaccharides Glucose 23 +_ 4 %30 Chemical composition of the nitrogen-containing polysaccharide; polysaccharide fraction Composition in monosaccharides Glucose 23 + _ 4%
Mannose 7lf +_ 5 % 35 Autres 5 +_ 3 % (*) 6 *Mannose 7lf + _ 5% 35 Others 5 + _ 3% (*) 6 *
Tableau II (suite)Table II (continued)
Structure à l'aide de la dégradation de SMITH-UNION 1-6 princi-' paiement.Structure using the degradation of SMITH-UNION 1-6 main payment.
5 (*) Principalement ribose, qui provient probablement d'un peu de conta mination par acides nucléiques.5 (*) Mainly ribose, which probably comes from a little contamination by nucleic acids.
Tableau IIITable III
Composition chimique du polysaccharide azoté ; fraction polysaccharide Dérivés acétylés ( par CGL ) (%) DEChemical composition of the nitrogenous polysaccharide; polysaccharide fraction Acetylated derivatives (by CGL) (%) DE
10 Glycérol 90,510 Glycerol 90.5
Mannitol 4,1Mannitol 4.1
Glucitol 2,9Glucitol 2.9
Autres 2,5Others 2.5
Tableau IVTable IV
15 Composition en aminoacides % en p/p15 Amino acid composition% in w / w
Phosphosérine 0,73 0,16Phosphoserine 0.73 0.16
Acide aspartique 10,6 +.0,28Aspartic acid 10.6 + 0.28
Thréonine 9,2 _+ 0,83 20 Sérine 8,01 _+ 0,32Threonine 9.2 _ + 0.83 20 Serine 8.01 _ + 0.32
Acide glutamique 17,6 _+ 1,22Glutamic acid 17.6 _ + 1.22
Proline 6,1 _+ 1,4Proline 6.1 _ + 1.4
Glycine 18 _+ 0,05Glycine 18 _ + 0.05
Alanine 3,9 +_ 0,2 25 Acide amino-butyrique 3,5 _+ 0,25Alanine 3.9 + _ 0.2 25 Amino-butyric acid 3.5 _ + 0.25
Valine 2,5 +0,16Valine 2.5 + 0.16
Cystéine 3,2 _+ 0,23 Méthionine 0,62^+0,31Cysteine 3.2 _ + 0.23 Methionine 0.62 ^ + 0.31
Isoleucine 3,05 _+ 0,13 30 Leucine 5,4 _+0,17Isoleucine 3.05 _ + 0.13 30 Leucine 5.4 _ + 0.17
Tyrosine 2,8 _+ 0,16Tyrosine 2.8 _ + 0.16
Phénylalanine 1,87 _+0,1Phenylalanine 1.87 _ + 0.1
Ornitine 0,17^0,02Ornitine 0.17 ^ 0.02
Lysine 9,2 _+ 0,52 35 Histidine 2,15 _+ 0,38Lysine 9.2 _ + 0.52 35 Histidine 2.15 _ + 0.38
Arginine 6,65 _+ 0,36Arginine 6.65 _ + 0.36
PP
77
PP
La Figure annexée donne le spectre dans l'infrarouge de deux échantillons du polysaccharide contenant de l'azote, à l'état pur, obtenus au départ de deux lots différents de produit d'adsorption. Comme on peut le voir, les spectres obtenus sont égaux. La position 5 des bandes les plus importantes (en cm L) se situe à : 3.400, 2.940, 1.660, 1.135, 1.060, 980 et 815.The appended figure gives the infrared spectrum of two samples of the polysaccharide containing nitrogen, in the pure state, obtained from two different batches of adsorption product. As can be seen, the spectra obtained are equal. The position 5 of the most important bands (in cm L) is located at: 3.400, 2.940, 1.660, 1.135, 1.060, 980 and 815.
Les polysaccharides suivant l'invention sont utilisables notamment à titre d'agents thérapeutiques, en particulier à titre d'im-munostimulants, notamment pour la stimulation des défenses organiques, 10 des états immunodéficitaires secondaires et des problèmes d'immunodéficience en général.The polysaccharides according to the invention can be used in particular as therapeutic agents, in particular as imunostimulants, in particular for the stimulation of organic defenses, secondary immunodeficiency states and immunodeficiency problems in general.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES543855 | 1985-06-03 | ||
ES543855A ES8701229A1 (en) | 1985-06-03 | 1985-06-03 | Process for producing a nitrogen-containing polysaccharide isolated in the form of an adsorbate |
Publications (1)
Publication Number | Publication Date |
---|---|
LU86418A1 true LU86418A1 (en) | 1986-12-02 |
Family
ID=8489318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU86418A LU86418A1 (en) | 1985-06-03 | 1986-05-02 | NITROGENED POLYSACCHARIDES AND THEIR PROCESS FOR OBTAINING |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE904716A (en) |
DE (1) | DE3617368C2 (en) |
ES (1) | ES8701229A1 (en) |
FR (1) | FR2582672B1 (en) |
IT (1) | IT1204830B (en) |
LU (1) | LU86418A1 (en) |
NL (1) | NL8601154A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2027518A6 (en) * | 1990-12-18 | 1992-06-01 | Andromaco Lab | A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity. |
TWI415942B (en) * | 2009-10-15 | 2013-11-21 | Food Industry Res & Dev Inst | Methods for producing exopolysaccharides and a novel pediococcus acidilactici isolate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3924994A (en) * | 1971-02-27 | 1975-12-09 | Katashi Aoki | Injection device for synthetic resin injection molding |
-
1985
- 1985-06-03 ES ES543855A patent/ES8701229A1/en not_active Expired
-
1986
- 1986-01-16 FR FR868600543A patent/FR2582672B1/en not_active Expired - Fee Related
- 1986-03-11 IT IT19689/86A patent/IT1204830B/en active
- 1986-05-02 LU LU86418A patent/LU86418A1/en unknown
- 1986-05-02 BE BE0/216619A patent/BE904716A/en not_active IP Right Cessation
- 1986-05-06 NL NL8601154A patent/NL8601154A/en not_active Application Discontinuation
- 1986-05-23 DE DE3617368A patent/DE3617368C2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES543855A0 (en) | 1986-11-16 |
DE3617368C2 (en) | 1994-11-24 |
FR2582672A1 (en) | 1986-12-05 |
ES8701229A1 (en) | 1986-11-16 |
FR2582672B1 (en) | 1990-02-02 |
IT8619689A0 (en) | 1986-03-11 |
NL8601154A (en) | 1987-01-02 |
DE3617368A1 (en) | 1987-01-15 |
IT1204830B (en) | 1989-03-10 |
BE904716A (en) | 1986-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU86418A1 (en) | NITROGENED POLYSACCHARIDES AND THEIR PROCESS FOR OBTAINING | |
FR2459289A1 (en) | PROCESS FOR THE PREPARATION OF THE ANTIBIOTIC CEPHAMYCIN C | |
JPS608797B2 (en) | Polysaccharide M-30-C | |
CN1772916A (en) | Chemical enzymatic process of synthesizing glutathion | |
EP0297944B1 (en) | Production of beta-glucuronidase type enzyme, hydrolysis of glycyrrhizine and of beta-glycyrrhetinic acid | |
KR101040099B1 (en) | Process for production of 5-ene-3-one or 3,6-dione derivatives of sterols, and analytical method | |
CA1122526A (en) | Biologically active substance, preparation process and drugs containing same | |
KR0149831B1 (en) | Health food by complex enzyme and processing method of it | |
JPS60141293A (en) | Novel carcinostatic antibiotic substance 81-484 and its production | |
CH643299A5 (en) | PROCESS FOR THE PREPARATION OF D-ALPHA-AMINO-ACIDS. | |
CH643592A5 (en) | PROCESS FOR PRODUCING 2,5-DICETOGLUCONIC ACID. | |
FR2476128A1 (en) | MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF NARASIN AND CROPS CONTAINING THE PRODUCING MICROORGANISM STREPTOMYCES LYDICUS DEBOER AND AL- | |
JP3030896B2 (en) | WB968 substance group and production method thereof | |
CA2123587A1 (en) | Bactericide product; pharmaceutical composition and food additive containing the same | |
FR2499855A1 (en) | NOVEL CARCINOSTATIC AND IMMUNO-STIMULATING ACTION SUBSTANCES, PROCESS FOR THEIR PREPARATION FROM BACTERIA OF THE GENUS FUSOBACTERIUM, AND CARCINOSTATIC AGENT CONTAINING SUCH SUBSTANCES | |
FR2598085A1 (en) | NOVEL ALDOSE REDUCTASE INHIBITING SUBSTANCE AND PROCESS FOR PREPARING THE SAME | |
FR2524886A1 (en) | ||
BE542271A (en) | ||
BE572570A (en) | ||
CH346976A (en) | Process for preparing a new antibiotic | |
JPS5945894A (en) | Preparation of coenzyme q10 | |
JPS62195290A (en) | Production of gamma-halo-beta-hydroxybutyric ester | |
BE555769A (en) | ||
CH354093A (en) | Process for preparing L-6-diazo-5-oxo-norleucine | |
JPS6399089A (en) | Kbs3-p1003 substance and production thereof |